🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Nageatte Ibrahim

ORCID: 0000-0003-0794-949X
MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma”.

Long-term safety of pembrolizumab monotherapy and relationship with clinical outcome: A landmark analysis in patients with advanced melanoma

European Journal of Cancer(2020)10.1016/j.ejca.2020.11.010
N/A
3.9DataRank · unranked
100 citations

Wen-Jen Hwu, Omid Hamid, Antoni Ribas, Jeffrey S. Weber, Adil Daud +18 more

Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

Cancer Discovery(2021)10.1158/2159-8290.cd-21-1141
N/A
0DataRank · unranked
102 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Data from Adjuvant Pembrolizumab versus IFNα2b or Ipilimumab in Resected High-Risk Melanoma

(2023)10.1158/2159-8290.c.6549583.v1
N/A
0DataRank · unranked
0 citations

Megan Othus, Sapna P. Patel, Ahmad A. Tarhini, Vernon K. Sondak, Michael V. Knopp +26 more

Supplementary Figure 3 from Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma

(2023)10.1158/2326-6066.22537789
N/A
0DataRank · unranked
0 citations

Donald P. Lawrence, Cecilia Lezcano, Xinqi Wu, Jun Zhou, Tetsuro Sasada +18 more